The biotech sector continues to be in focus with regulatory and pipeline updates from fairly a number of corporations. New drug approvals are additionally within the highlight. The sector has additionally been in focus, due to the event of antibodies and vaccines for coronavirus gaining significance wi
www.nasdaq.com
Biotech Inventory Roundup: Regulatory Updates From REGN, INCY, & Different Updates
